{"nct_id":"NCT05033132","title":"A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer","status":"WITHDRAWN","status_verified_date":"2024-03","start_date":"2021-10-01","start_date_type":"ACTUAL","primary_completion_date":"2024-12-30","primary_completion_date_type":"ESTIMATED","completion_date":"2024-12-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AGEN"]}